The Munich-based health startup Temedica has secured a Series B financing 17 million euros The lead investors are MIG Fonds, Santo Venture Capital, and Salvia. Existing shareholders such as Bernd Wendeln and G+J Digital Ventures have also reinvested. (Photo: Temedica)
